Literature DB >> 31924696

FLNC truncations cause arrhythmogenic right ventricular cardiomyopathy.

Francesca Brun1, Marta Gigli1, Sharon L Graw2, Daniel P Judge3, Marco Merlo1, Brittney Murray4, Hugh Calkins4, Gianfranco Sinagra1, Matthew Rg Taylor2,5, Luisa Mestroni6, Cynthia A James4.   

Abstract

BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heart muscle disease that affects predominantly the right ventricle and is part of the spectrum of arrythmogenic cardiomyopathies (ACMs). ARVC is a genetic condition; however, a pathogenic gene variant is found in only half of patients.
OBJECTIVE: Filamin C gene truncations (FLNCtv) have recently been identified in dilated cardiomyopathy with ventricular arrhythmia and sudden cardiac death, a phenotype partially overlapping with ARVC and part of the ACM spectrum. We hypothesised that FLNCtv could be a novel gene associated with ARVC.
METHODS: One hundred fifty-six patients meeting 2010 ARVC Task Force Criteria and lacking variants in known ARVC genes were evaluated for FLNC variants. Available family members were tested for cosegregation.
RESULTS: We identified two unique FLNCtv variants in two families (c.6565 G>T, p.Glu2189Ter and c.8107delG, p.Asp2703ThrfsTer69), with phenotypes of dominant RV disease fulfilling 'definite' diagnosis of ARVC according to the 2010 Task Force Criteria. Variants in other cardiomyopathy genes were excluded in both kindreds, and segregation analysis revealed that p.Asp2703ThrfsTer69 was a de novo variant. In both families, the disease phenotype was characterised by prominent ventricular arrhythmias and sudden cardiac arrest.
CONCLUSION: The identification of FLNCtv as a novel cause of ARVC in two unrelated families expands the spectrum of ARVC non-desmosome disease genes for this disorder. Our findings should prompt inclusion of FLNC genetic testing in ARVC to improve diagnostic yield and testing of at-risk relatives in ARVC. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  arrhythmias; arrhythmogenic cardiomyopathy; arrhythmogenic right ventricular cardiomyopathy; dilated cardiomyopathy; filamin C; sudden cardiac death

Mesh:

Substances:

Year:  2020        PMID: 31924696      PMCID: PMC7539291          DOI: 10.1136/jmedgenet-2019-106394

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  21 in total

1.  Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria.

Authors:  Frank I Marcus; William J McKenna; Duane Sherrill; Cristina Basso; Barbara Bauce; David A Bluemke; Hugh Calkins; Domenico Corrado; Moniek G P J Cox; James P Daubert; Guy Fontaine; Kathleen Gear; Richard Hauer; Andrea Nava; Michael H Picard; Nikos Protonotarios; Jeffrey E Saffitz; Danita M Yoerger Sanborn; Jonathan S Steinberg; Harikrishna Tandri; Gaetano Thiene; Jeffrey A Towbin; Adalena Tsatsopoulou; Thomas Wichter; Wojciech Zareba
Journal:  Eur Heart J       Date:  2010-02-19       Impact factor: 29.983

Review 2.  Dilated Cardiomyopathy: Genetic Determinants and Mechanisms.

Authors:  Elizabeth M McNally; Luisa Mestroni
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

Review 3.  Arrhythmogenic Cardiomyopathy.

Authors:  Domenico Corrado; Cristina Basso; Daniel P Judge
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

Review 4.  Diagnostic Criteria, Genetics, and Molecular Basis of Arrhythmogenic Cardiomyopathy.

Authors:  Cristina Basso; Kalliopi Pilichou; Barbara Bauce; Domenico Corrado; Gaetano Thiene
Journal:  Heart Fail Clin       Date:  2018-04       Impact factor: 3.179

5.  Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies.

Authors:  Martín F Ortiz-Genga; Sofía Cuenca; Matteo Dal Ferro; Esther Zorio; Ricardo Salgado-Aranda; Vicente Climent; Laura Padrón-Barthe; Iria Duro-Aguado; Juan Jiménez-Jáimez; Víctor M Hidalgo-Olivares; Enrique García-Campo; Chiara Lanzillo; M Paz Suárez-Mier; Hagith Yonath; Sonia Marcos-Alonso; Juan P Ochoa; José L Santomé; Diego García-Giustiniani; Jorge L Rodríguez-Garrido; Fernando Domínguez; Marco Merlo; Julián Palomino; María L Peña; Juan P Trujillo; Alicia Martín-Vila; Davide Stolfo; Pilar Molina; Enrique Lara-Pezzi; Francisco E Calvo-Iglesias; Eyal Nof; Leonardo Calò; Roberto Barriales-Villa; Juan R Gimeno-Blanes; Michael Arad; Pablo García-Pavía; Lorenzo Monserrat
Journal:  J Am Coll Cardiol       Date:  2016-12-06       Impact factor: 24.094

6.  Prevalence of desmosomal protein gene mutations in patients with dilated cardiomyopathy.

Authors:  Perry Elliott; Constantinos O'Mahony; Petros Syrris; Alison Evans; Christina Rivera Sorensen; Mary N Sheppard; Gerald Carr-White; Antonios Pantazis; William J McKenna
Journal:  Circ Cardiovasc Genet       Date:  2010-08

7.  Family members of patients with ARVC: who is at risk? At what age? When and how often should we evaluate to determine risk?

Authors:  Frank Marcus; Luisa Mestroni
Journal:  J Am Coll Cardiol       Date:  2014-07-22       Impact factor: 24.094

8.  Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy.

Authors:  Marta Gigli; Marco Merlo; Sharon L Graw; Giulia Barbati; Teisha J Rowland; Dobromir B Slavov; Davide Stolfo; Mary E Haywood; Matteo Dal Ferro; Alessandro Altinier; Federica Ramani; Francesca Brun; Andrea Cocciolo; Ilaria Puggia; Gaetano Morea; William J McKenna; Francisco G La Rosa; Matthew R G Taylor; Gianfranco Sinagra; Luisa Mestroni
Journal:  J Am Coll Cardiol       Date:  2019-09-17       Impact factor: 24.094

9.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

10.  FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy.

Authors:  Rene L Begay; Charles A Tharp; August Martin; Sharon L Graw; Gianfranco Sinagra; Daniela Miani; Mary E Sweet; Dobromir B Slavov; Neil Stafford; Molly J Zeller; Rasha Alnefaie; Teisha J Rowland; Francesca Brun; Kenneth L Jones; Katherine Gowan; Luisa Mestroni; Deborah M Garrity; Matthew R G Taylor
Journal:  JACC Basic Transl Sci       Date:  2016-07-27
View more
  15 in total

1.  Clinical and genetic features of arrhythmogenic cardiomyopathy: diagnosis, management and the heart failure perspective.

Authors:  Matteo Castrichini; Ramone Eldemire; Daniel W Groves; Matthew Rg Taylor; Shelley Miyamoto; Luisa Mestroni
Journal:  Prog Pediatr Cardiol       Date:  2021-11-02

Review 2.  Emerging Genotype-Phenotype Associations in Dilated Cardiomyopathy.

Authors:  Joyce N Njoroge; Jennifer C Mangena; Chiaka Aribeana; Victoria N Parikh
Journal:  Curr Cardiol Rep       Date:  2022-07-28       Impact factor: 3.955

3.  Loss-of-Function FLNC Variants Are Associated With Arrhythmogenic Cardiomyopathy Phenotypes When Identified Through Exome Sequencing of a General Clinical Population.

Authors:  Eric D Carruth; Maria Qureshi; Amro Alsaid; Melissa A Kelly; Hugh Calkins; Brittney Murray; Crystal Tichnell; Amy C Sturm; Aris Baras; H Lester Kirchner; Brandon K Fornwalt; Cynthia A James; Christopher M Haggerty
Journal:  Circ Genom Precis Med       Date:  2022-06-14

Review 4.  Understanding the molecular basis of cardiomyopathy.

Authors:  Marie-Louise Bang; Julius Bogomolovas; Ju Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-11-19       Impact factor: 5.125

5.  Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants.

Authors:  Marta Gigli; Davide Stolfo; Sharon L Graw; Marco Merlo; Caterina Gregorio; Suet Nee Chen; Matteo Dal Ferro; Alessia PaldinoMD; Giulia De Angelis; Francesca Brun; Jean Jirikowic; Ernesto E Salcedo; Sylvia Turja; Diane Fatkin; Renee Johnson; J Peter van Tintelen; Anneline S J M Te Riele; Arthur A M Wilde; Neal K Lakdawala; Kermshlise Picard; Daniela Miani; Daniele Muser; Giovanni Maria Severini; Hugh Calkins; Cynthia A James; Brittney Murray; Crystal Tichnell; Victoria N Parikh; Euan A Ashley; Chloe Reuter; Jiangping Song; Daniel P Judge; William J McKenna; Matthew R G Taylor; Gianfranco Sinagra; Luisa Mestroni
Journal:  Circulation       Date:  2021-09-30       Impact factor: 29.690

Review 6.  Genetics of dilated cardiomyopathy.

Authors:  Suet Nee Chen; Luisa Mestroni; Matthew R G Taylor
Journal:  Curr Opin Cardiol       Date:  2021-05-01       Impact factor: 2.108

Review 7.  Atomic Force Microscopy (AFM) Applications in Arrhythmogenic Cardiomyopathy.

Authors:  Brisa Peña; Mostafa Adbel-Hafiz; Maria Cavasin; Luisa Mestroni; Orfeo Sbaizero
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

Review 8.  Current Understanding of the Role of Cytoskeletal Cross-Linkers in the Onset and Development of Cardiomyopathies.

Authors:  Ilaria Pecorari; Luisa Mestroni; Orfeo Sbaizero
Journal:  Int J Mol Sci       Date:  2020-08-15       Impact factor: 5.923

Review 9.  Cardiac Filaminopathies: Illuminating the Divergent Role of Filamin C Mutations in Human Cardiomyopathy.

Authors:  Matthias Eden; Norbert Frey
Journal:  J Clin Med       Date:  2021-02-04       Impact factor: 4.241

Review 10.  Structure and Function of Filamin C in the Muscle Z-Disc.

Authors:  Zhenfeng Mao; Fumihiko Nakamura
Journal:  Int J Mol Sci       Date:  2020-04-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.